NEWS

Venturelab interview with Avrion CEO Maximilien Murone

Avrion CEO Maximilien Murone discusses Avrion and the future of gene therapies with Venturelab
"Avrion comes from the ancient Greek word of tomorrow, as we see ourselves as developers of therapies of tomorrow, addressing disorders for which there is currently no meaningful treatment" - Read the full interview here.
AVRION UPDATES